Chronic hepatitis B is one of the most common epidemic diseases in China and has become a majorhealth issue. To help standardize the prevention, diagnosis, and treatment of chronic hepatitis B, the Guideline on preven...Chronic hepatitis B is one of the most common epidemic diseases in China and has become a majorhealth issue. To help standardize the prevention, diagnosis, and treatment of chronic hepatitis B, the Guideline on prevention and treatment of chronic hepatitis B （abbr. Guideline） was created by a group of appropriate experts belonging to the Society of Hepatology and the Society of Infectious Disease, the Chinese Medical Association according to the principles of evidence-based medicine using the latest clinical research data. The evidence used to formulate the recommendation has been classified into 3 classes and 5 grades, which are indicated by Roman numerals in brackets.展开更多
目的了解临床医师的高血压防治观念和对新版高血压防治指南的修订意见。方法 2011年5月至10月在全国大、中城市随机选取89个城市医院(以三甲医院为主)的临床医师进行调查。共1570位临床医师参加了调查,数据完整的问卷1570份。问卷内容...目的了解临床医师的高血压防治观念和对新版高血压防治指南的修订意见。方法 2011年5月至10月在全国大、中城市随机选取89个城市医院(以三甲医院为主)的临床医师进行调查。共1570位临床医师参加了调查,数据完整的问卷1570份。问卷内容主要包括临床医师对正常高值血压的处理、心血管危险分层、特殊人群降压适宜的目标、生活方式改善的具体内容、传统降压药物的评价与推荐、固定剂量复方制剂的前景及应如何推荐等问题。结果 83.6%的医师认为对正常高值血压合并多种心血管危险因素、糖尿病、心血管疾病或肾脏疾病的高危患者,在生活方式改善的基础上应及早进行药物治疗。92.7%的医师以心血管危险分层作为高血压治疗的依据,但78.3%的医师认为危险分层的内容需要简化。90.3%的医师认为糖尿病患者的目标血压是<130/80 mm Hg(1 mm Hg=0.133 k Pa),5.5%认为如能耐受,越低越好。53.9%的医师认为脑血管病后患者的目标血压应该是<130/80 mm Hg,41.1%认为是<140/90mm Hg。64.6%的医师认为冠心病患者目标血压是<130/80 mm Hg,28.1%认为是<140/90 mm Hg。79.8%的医师认为慢性肾脏病患者的目标血压应该是<130/80 mm Hg,11.5%认为如能耐受越低越好。98.3%的医师认为,新版指南需要将减少钠盐摄入的措施具体化,92.0%的医师认为,新版指南需要将戒烟的措施具体化。69.9%的医师认为固定剂量复方制剂是降压药物的发展趋势。结论大部分医师认可并遵循2010版《中国高血压防治指南》,并对新版指南提出修改意见。展开更多
文摘Chronic hepatitis B is one of the most common epidemic diseases in China and has become a majorhealth issue. To help standardize the prevention, diagnosis, and treatment of chronic hepatitis B, the Guideline on prevention and treatment of chronic hepatitis B （abbr. Guideline） was created by a group of appropriate experts belonging to the Society of Hepatology and the Society of Infectious Disease, the Chinese Medical Association according to the principles of evidence-based medicine using the latest clinical research data. The evidence used to formulate the recommendation has been classified into 3 classes and 5 grades, which are indicated by Roman numerals in brackets.
文摘目的了解临床医师的高血压防治观念和对新版高血压防治指南的修订意见。方法 2011年5月至10月在全国大、中城市随机选取89个城市医院(以三甲医院为主)的临床医师进行调查。共1570位临床医师参加了调查,数据完整的问卷1570份。问卷内容主要包括临床医师对正常高值血压的处理、心血管危险分层、特殊人群降压适宜的目标、生活方式改善的具体内容、传统降压药物的评价与推荐、固定剂量复方制剂的前景及应如何推荐等问题。结果 83.6%的医师认为对正常高值血压合并多种心血管危险因素、糖尿病、心血管疾病或肾脏疾病的高危患者,在生活方式改善的基础上应及早进行药物治疗。92.7%的医师以心血管危险分层作为高血压治疗的依据,但78.3%的医师认为危险分层的内容需要简化。90.3%的医师认为糖尿病患者的目标血压是<130/80 mm Hg(1 mm Hg=0.133 k Pa),5.5%认为如能耐受,越低越好。53.9%的医师认为脑血管病后患者的目标血压应该是<130/80 mm Hg,41.1%认为是<140/90mm Hg。64.6%的医师认为冠心病患者目标血压是<130/80 mm Hg,28.1%认为是<140/90 mm Hg。79.8%的医师认为慢性肾脏病患者的目标血压应该是<130/80 mm Hg,11.5%认为如能耐受越低越好。98.3%的医师认为,新版指南需要将减少钠盐摄入的措施具体化,92.0%的医师认为,新版指南需要将戒烟的措施具体化。69.9%的医师认为固定剂量复方制剂是降压药物的发展趋势。结论大部分医师认可并遵循2010版《中国高血压防治指南》,并对新版指南提出修改意见。
